Page last updated: 2024-09-05

kwd 2131 and Asthma

kwd 2131 has been researched along with Asthma in 7 studies

*Asthma: A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL). [MeSH]

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	7 (100.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hegardt, B; Löwhagen, O; Svedmyr, N	3
Pegelow, KO; Strandberg, K	1
Hegardt, B; Pauwels, R; Van Der Straeten, M	2
Lowhagen, O	1

Trials

6 trial(s) available for kwd 2131 and Asthma

Article	Year
New beta-agonist, KWD 2131, compared with terbutaline in asthmatics. A cumulative dose-response study. Allergy, 1980, Volume: 35, Issue:2 Topics: Adrenergic beta-Agonists; Adult; Aerosols; Aged; Asthma; Bronchodilator Agents; Chemical Phenomena; Chemistry; Clinical Trials as Topic; Dose-Response Relationship, Drug; Female; Forced Expiratory Volume; Humans; Male; Middle Aged; Terbutaline	1980
Histamine-induced bronchospasm. Its reproducibility and usage in clinical evaluation of the sub-threshold bronchodilating dose of a new beta-agonist, KWD 2131. Allergy, 1980, Volume: 35, Issue:2 Topics: Adrenergic beta-Agonists; Adult; Asthma; Bronchial Provocation Tests; Bronchial Spasm; Bronchodilator Agents; Clinical Trials as Topic; Dose-Response Relationship, Drug; Female; Forced Expiratory Volume; Histamine; Humans; Male; Middle Aged; Terbutaline	1980
Evaluation of the protective effect of a new beta-agonist, KWD 2131, on allergen-induced bronchospasm. Allergy, 1980, Volume: 35, Issue:5 Topics: Adrenergic beta-Agonists; Adult; Allergens; Asthma; Bronchial Provocation Tests; Bronchial Spasm; Clinical Trials as Topic; Double-Blind Method; Female; Forced Expiratory Volume; Humans; Male; Placebos; Terbutaline	1980
Evaluation of the bronchodilating and antiallergic properties of a beta-adrenoceptor stimulant, KWD 2131, in asthmatic patients. Allergy, 1980, Volume: 35, Issue:6 Topics: Adrenergic beta-Antagonists; Adult; Allergens; Asthma; Bronchodilator Agents; Chronic Disease; Clinical Trials as Topic; Dose-Response Relationship, Drug; Female; Heart Rate; Histamine; Humans; Hypersensitivity; Male; Peak Expiratory Flow Rate; Random Allocation; Terbutaline; Tremor	1980
Inhibitory effect of KWD 2131, terbutaline, and DSCG on the immediate and late allergen-induced bronchoconstriction. Allergy, 1981, Volume: 36, Issue:2 Topics: Adrenergic beta-Agonists; Adult; Asthma; Bronchial Provocation Tests; Bronchial Spasm; Clinical Trials as Topic; Cromolyn Sodium; Female; Forced Expiratory Volume; Humans; Male; Random Allocation; Terbutaline	1981
Therapeutic modulation of bronchial hyperreactivity. European journal of respiratory diseases. Supplement, 1982, Volume: 117 Topics: Asthma; Bronchodilator Agents; Clinical Trials as Topic; Cromolyn Sodium; Double-Blind Method; Humans; Ketotifen; Phenanthrolines; Respiratory Hypersensitivity; Terbutaline	1982

Other Studies

1 other study(ies) available for kwd 2131 and Asthma

Article	Year
Evaluation of immediate- and late-response inhibition of a new beta-agonist, KWD 2131, compared with terbutaline and DSCG. International archives of allergy and applied immunology, 1981, Volume: 66 Suppl 1 Topics: Asthma; Bronchial Provocation Tests; Cromolyn Sodium; Drug Evaluation; Humans; Lung Volume Measurements; Random Allocation; Terbutaline	1981